4//SEC Filing
T2 Biosystems, Inc. 4
Accession 0001104659-15-058048
CIK 0001492674operating
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 11:00 AM ET
Size
5.3 KB
Accession
0001104659-15-058048
Insider Transaction Report
Form 4
CASTONGUAY MAURICE L
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-08-06+146,000→ 146,000 totalExercise: $14.04Exp: 2025-08-06→ Common Stock (146,000 underlying)
Footnotes (1)
- [F1]25% of the total shares vest on 08/06/2016, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 08/06/2019.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492674
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 11:00 AM ET
- Size
- 5.3 KB